Booster-effect with velaglucerase alfa in patients with Gaucher disease switched from long-term imiglucerase therapy: Early Access Program results from Jerusalem

Autor: Elstein, Deborah, Altarescu, Gheona, Maayan, Hannah, Phillips, Mici, Abrahamov, Aya, Hadas-Halpern, Irith, Tiomkin, Maayan, Zimran, Ari
Zdroj: In Blood Cells, Molecules and Diseases 2012 48(1):45-50
Databáze: ScienceDirect